AI Patent Analysis Toolkit
PatentAgility
by KellDann

Examiner Dr. Katie L Pennington

Examiner Dr. Katie L Pennington appears to be about average relative to their peer examiners. Their lifetime grant ratio is 6.4%, they average 1.63 office actions per granted patent, and their rejection profile is dominated by ยง103.

Difficulty vs AU About Average
Difficulty vs Group About Average
Difficulty vs TC About Average
Difficulty vs USPTO About Average
Average OA / Grant 1.63
Export
Word PDF

Create account to export.

Examiner Details

Observed Examiner Years
4 years (2023-2026)
Phone
(703) 756-4622
Predicted Supervisor
Maria G. Leavitt
Supervisor Phone
(571) 272-1085
Tech Center
1600 - Biotechnology and Organic
Group
1630 - Stem Cells and Nucleic Acid Related Therapy

Metrics

Applications Evaluated
125
Granted Applications
8
Non-Granted Applications
117
Avg OA / Grant
1.63
Last OA Observed
June 2026 (1 months ago)
Art Units Seen
1633 , 1634
Work Groups Seen

Context Comparison

Scope Examiners Lifetime Grant Ratio Avg OA / Grant
This Examiner 1 6.4% 1.63
Art Unit 32 34.4% 2.44
Group 245 37.7% 2.18
Tech Center 1,365 38.5% 2.02
USPTO 16,346 53.5% 1.98

Grant Timeline

0.0% 25.0% 50.0% 75.0% 100.0% 2023 2024 2025 2026
Shaded region marks the last two observed years, where grant outcomes may lag due to recency.
Year Applications Granted Grant Rate
No observed data before 2023; examiner may not yet have been active in the available dataset.
2023 3 0 0.0%
2024 28 6 21.4%
2025 30 2 6.7%
2026 64 0 0.0%

8 family-cache-validated grants; 0 OA-only grant signals.

Rejection Timeline

OA # Office Actions § 101 Percentage § 102 Percentage § 103 Percentage § 112 Percentage
1 119 0.0% 8.4% 63.9% 1.7%
2 74 1.4% 8.1% 77.0% 1.4%
3 34 0.0% 2.9% 70.6% 8.8%
4 17 0.0% 0.0% 70.6% 11.8%
5 3 0.0% 33.3% 66.7% 0.0%
6 1 0.0% 0.0% 100.0% 0.0%
15 1 0.0% 0.0% 100.0% 0.0%
16 1 0.0% 0.0% 100.0% 0.0%

§ 101 Yearly Trend

2024: AI Examples
2025: Aug. Memo
0.0%
2023
1.4%
2024
0.0%
2025
0.0%
2026

Each bar shows the share of this examiner's observed office actions in that year that included a § 101 rejection.